CSIMarket
 


Sotera Health Company  (SHC)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

SHC's Capital Expenditures Growth by Quarter and Year

Sotera Health's Capital Expenditures results by quarter and year




SHC Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 64.83 71.74 41.26 0.00
III Quarter September 52.02 39.00 16.11 0.00
II Quarter June 53.13 36.10 23.85 0.00
I Quarter March 45.00 35.55 20.94 0.00
FY   214.98 182.39 102.16 0.00



SHC Capital Expenditures fourth quarter 2023 Y/Y Growth Comment
Sotera Health Company reported decrease in Capital Expenditures in the fourth quarter 2023 by -9.64% to $ 64.83 millions, from the same quarter in 2022.
The decrease in the fourth quarter 2023 Sotera Health Company's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures jump of 43.63%.

Looking into fourth quarter 2023 results within Healthcare Facilities industry 2 other companies have achieved higher Capital Expenditures growth. While Sotera Health Company' s Capital Expenditures decline of -9.64% ranks overall at the positon no. 449 in the fourth quarter 2023.




SHC Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -9.64 % 73.87 % - -
III Quarter September 33.38 % 142.09 % - -
II Quarter June 47.17 % 51.36 % - -
I Quarter March 26.58 % 69.77 % - -
FY   17.87 % 78.53 % - -

Financial Statements
Sotera Health's fourth quarter 2023 Capital Expenditures $ 64.83 millions SHC's Income Statement
Sotera Health's fourth quarter 2022 Capital Expenditures $ 71.74 millions Quarterly SHC's Income Statement
New: More SHC's historic Capital Expenditures Growth >>


SHC Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 24.62 % 83.95 % 156.11 % -
III Quarter September -2.09 % 8.03 % -32.45 % -
II Quarter June 18.07 % 1.55 % 13.9 % -
I Quarter March -37.27 % -13.84 % - -
FY (Year on Year)   17.87 % 78.53 % - -




Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #3
Healthcare Sector #53
Overall #449

Capital Expenditures Y/Y Growth Statistics
High Average Low
78.52 % 43.63 % -6.84 %
(Dec 31 2022)   (Sep 30 2022)
Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #3
Healthcare Sector #53
Overall #449
Capital Expenditures Y/Y Growth Statistics
High Average Low
78.52 % 43.63 % -6.84 %
(Dec 31 2022)   (Sep 30 2022)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Sotera Health's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
156.15 % 20.05 % -37.27 %
(Dec 31 2021)  


SHC's IV. Quarter Q/Q Capital Expenditures Comment
Sotera Health Company achieved in the IV. Quarter 2023 above company average sequential Capital Expenditures jump of 24.62%, to $ 64.83 millions, from $52.02 millions in the third quarter.

Within Healthcare Facilities industry 6 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Sotera Health's Capital Expenditures growth quarter on quarter, overall rank is 540.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #7
Healthcare Sector #81
Overall #540
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #7
Healthcare Sector #81
Overall #540
Capital Expenditures Q/Q Growth Statistics
High Average Low
156.15 % 20.05 % -37.27 %
(Dec 31 2021)  


SHC's IV. Quarter Q/Q Capital Expenditures Comment
Sotera Health Company achieved in the IV. Quarter 2023 above company average sequential Capital Expenditures jump of 24.62%, to $ 64.83 millions, from $52.02 millions in the third quarter.

Within Healthcare Facilities industry 6 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Sotera Health's Capital Expenditures growth quarter on quarter, overall rank is 540.


Sotera Health's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Capital Expenditures 12 Months Ending $ 214.98 $ 221.89 $ 208.87 $ 191.83 $ 182.38
Y / Y Capital Expenditures Growth (TTM) 17.87 % 46.07 % 61.9 % 64.29 % 78.52 %
Year on Year Capital Expenditures Growth Overall Ranking # 113 # 471 # 802 # 809 # 1702
Seqeuential Capital Expenditures Change (TTM) -3.11 % 6.23 % 8.88 % 5.18 % 20.06 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 449 # 271 # 595 # 572 # 2077




Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Dec 31 2023 period, Sotera Health's cumulative twelve months Capital Expenditures were $ 215 millions, company would post below average annual Capital Expenditures growth of 20.06% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the Sotera Health's Capital Expenditures growth from the 52.02% growth in Sep 30 2023.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 113, from total ranking in previous quarter at 471.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
78.52 %
43.63 %
-6.84 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 3
Healthcare Sector # 18
Overall # 113

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
78.52 %
43.63 %
-6.84 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 53
S&P 500 # 449
Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Dec 31 2023 period, Sotera Health's cumulative twelve months Capital Expenditures were $ 215 millions, company would post below average annual Capital Expenditures growth of -6.84% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the Sotera Health's Capital Expenditures growth from the 52.02% growth in Sep 30 2023.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 113, from total ranking in previous quarter at 471.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
78.52 %
43.63 %
-6.84 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 3
Healthcare Sector # 18
Overall # 113

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
78.52 %
43.63 %
-6.84 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 53
S&P 500 # 449




Other Capital Expenditures Growth
Healthcare Facilities Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
SHC's Capital Expenditures Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for SHC's Competitors
Capital Expenditures Growth for Sotera Health's Suppliers
Capital Expenditures Growth for SHC's Customers

You may also want to know
SHC's Annual Growth Rates SHC's Profitability Ratios SHC's Asset Turnover Ratio SHC's Dividend Growth
SHC's Roe SHC's Valuation Ratios SHC's Financial Strength Ratios SHC's Dividend Payout Ratio
SHC's Roa SHC's Inventory Turnover Ratio SHC's Growth Rates SHC's Dividend Comparisons



Companies with similar Capital Expenditures jump for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2023
Stereotaxis Inc -0.81%$ -0.813 millions
Icon Plc-1.03%$ -1.033 millions
Alpine Immune Sciences Inc -1.72%$ -1.724 millions
Argenx se-2.99%$ -2.987 millions
Abbvie inc -3.76%$ -3.756 millions
Vanda Pharmaceuticals Inc -3.80%$ -3.802 millions
Warby Parker Inc -4.52%$ -4.516 millions
Bristol myers Squibb Company-4.62%$ -4.624 millions
Baxter International Inc -5.00%$ -5.000 millions
Progyny Inc -5.55%$ -5.548 millions
Koru Medical Systems Inc-6.92%$ -6.916 millions
Ufp Technologies Inc -7.02%$ -7.018 millions
Bio rad Laboratories Inc -7.27%$ -7.272 millions
Endo International Plc-8.13%$ -8.130 millions
Eterna Therapeutics Inc -9.52%$ -9.524 millions
Sotera Health Company-9.63%$ -9.633 millions
Hutchmed china Limited-11.05%$ -11.052 millions
Petvivo Holdings Inc-11.46%$ -11.461 millions
Novartis Ag-11.52%$ -11.519 millions
Charles River Laboratories International inc -12.02%$ -12.020 millions
Surgery Partners Inc -12.78%$ -12.775 millions
Xbiotech Inc -12.88%$ -12.879 millions
Conmed Corporation-14.46%$ -14.464 millions
Msa Safety Incorporated-14.60%$ -14.601 millions
Teva Pharmaceutical Industries Limited-16.20%$ -16.197 millions
Genedx Holdings Corp -16.28%$ -16.279 millions
Dexcom Inc -17.32%$ -17.323 millions
Davita Inc -17.74%$ -17.739 millions
Voyager Therapeutics Inc -19.08%$ -19.078 millions
Natera inc -19.40%$ -19.405 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com